CPR offers new PR therapy for anti-cancer treatments

Pharmaceutical giant Bristol-Myers Squibb has handed Complete Pharma PR the pan-European business for its portfolio of anti-cancer products.

Pharmaceutical giant Bristol-Myers Squibb has handed Complete

Pharma PR the pan-European business for its portfolio of anti-cancer

products.



CPR won the six-figure account following a competitive two-way pitch

against Edelman London. The brief is to provide strategic communications

recommendations and creative concepts for Bristol-Myers Squibb’s full

portfolio of current and pipeline oncology products, which include

TAXOL, Paraplatin, Platinol and VePesid.



’A key task will be maintaining Bristol-Myers Squibb’s voice and

presence at key meetings throughout the world,’ said CPR managing

director Scott Clark.



CPR will target a wide-ranging audience, including healthcare

professionals, patients and their families.



The oncology account was previously handled by Burson-Marsteller, but

the agency and Bristol-Myers Squibb ended their contract by mutual

agreement at the beginning of the year. Shire Hall took over the account

for the Caring About Women Against Cancer campaign from B-M. The

campaign, which is launching at the beginning of 1998, covers 17

European countries. Shire Hall has also handled the account for TAXOL

for the last three and a half years for Bristol-Myers Squibb UK.



B-M continue to hold the accounts for Bristol-Myers Squibb’s

cardiovascular and cholestrol lowering products.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in